Coagulation Factor Concentrates Market

Coagulation Factor Concentrates Market contains market size and forecasts of Coagulation Factor Concentrates in global, including the following market information:

Global Coagulation Factor Concentrates Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Coagulation Factor Concentrates Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Coagulation Factor Concentrates companies in 2021 (%)

The global Coagulation Factor Concentrates market was valued at 6648.2 million in 2021 and is projected to reach US$ 9852.3 million by 2028, at a CAGR of 5.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Factor VIII Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Coagulation Factor Concentrates include CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France) and Biotest (Germany), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Coagulation Factor Concentrates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Coagulation Factor Concentrates Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Coagulation Factor Concentrates Market Segment Percentages, by Type, 2021 (%)

Factor VIII

Factor IX

Von Willebrand Factor

Prothrombin Complex Concentrates

Fibrinogen Concentrates

Factor XIII

Global Coagulation Factor Concentrates Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Coagulation Factor Concentrates Market Segment Percentages, by Application, 2021 (%)

Neurology

Immunology

Hematology

Critical Care

Pulmonology

Hemato-Oncology

Rheumatology

Others

Global Coagulation Factor Concentrates Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Coagulation Factor Concentrates Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Coagulation Factor Concentrates revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Coagulation Factor Concentrates revenues share in global market, 2021 (%)

Key companies Coagulation Factor Concentrates sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Coagulation Factor Concentrates sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CSL (Australia)

Grifols (Spain)

Shire (Ireland)

Octapharma (Switzerland)

Kedrion (Italy)

Bio Product Laboratory (UK)

Sanquin (Netherlands)

LFB (France)

Biotest (Germany)

Japan Blood Products Organization, China Biologic Products (China)

Green Cross Corporation (South Korea)

Shanghai RAAS Blood Products (China)